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Nanocomposite structure of the bone can be mimicked by chitosan/hydroxyapatite 
(CS/HAp) composite scaffold. Biological hydroxyapatite (HAp) contains various ions, 
which have a crucial role in bone growth. The aim of the present work was to synthesize 
biomimetic hydroxyapatite and prepare composite scaffolds based on chitosan, where 
HAp was synthesised from hen eggshells, seashells and cuttlefish bone. The powders 
were composed of nano-structured calcium deficient HAp and amorphous calcium phos-
phate (ACP). In the as-prepared powders, Sr2+, Mg2+ and Na+ ions were detected as a 
result of using biogenic precursor of Ca2+ ions. Highly porous CS/HAp structures have 
been prepared by freeze-gelation technique. The CS/HAp scaffolds have shown highly 
porous structure with very well interconnected pores and homogeneously dispersed HAp 
particles. The MTT assay of CS/HAp scaffolds has shown no toxicity, and the live/dead 
assay has confirmed good viability and proliferation of seeded cells.
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1. Introduction
Considering the improvement of people’s liv-
ing standard and increased life expectancy, it is cru-
cial to develop scaffolds for bone tissue engineering 
that fulfil various requirements such as bioactivity, 
biocompatibility, cell-scaffold adhesion, mechanical 
properties, and biodegradability1,2. A promising way 
to obtain appropriate scaffold is to mimic the struc-
ture, element content, and phase composition of 
natural bone tissue3–5.
Human bone consists of 65–70 % inorganic 
phase (calcium phosphates and trace elements), 
 20–25 % of organic phase (primarily collagen), and 
5–8 % of water6. Hydroxyapatite (Ca10(PO4)6(OH)2, 
HAp) is a calcium phosphate highly used in bone 
tissue engineering as scaffold, filler, drug delivery 
system, and bioactive coating, due to its bioactivity, 
osteoinductivity, biocompatibility, and chemical 
similarity to the mineral phase of bone tissue1,7,8. Bi-
ological HAp in its structure contains various trace 
elements, such as CO3
2–, Mg2+, Na+, K+, Zn2+, Sr2+, 
Cl–, F–, which have a crucial role in bone growth9,10. 
Incorporation of mentioned ions in synthetic HAp 
crystal lattice can affect its crystallinity, morpholo-
gy, lattice parameters, thermal stability, solubility, 
and phase composition, which can significantly im-
prove the biological properties of synthetic HAp 
bioceramics11.
Numerous methods have been developed for 
the synthesis of HAp, such as solid-state, mechano-
chemical, chemical precipitation, sol-gel, and hy-
drothermal methods, using various precursors of 
calcium and phosphate ions. However, in synthetic 
stoichiometric HAp there are no trace elements in 
its structure, which is why natural biogenic sources 
as potential materials for synthesis of biomimetic 
HAp have been investigated1,6,12. Calcium-rich 
sources, such as eggshells, seashells, animal bones, 
cuttlefish bone, and corals represent a promising fu-
ture of bioceramics because they naturally contain 
trace elements in their crystal lattice13. Additionally, 
using natural biogenic sources for HAp synthesis, 
bio-waste (e.g. eggshells, fish bones) is reduced and 
recycled, and it is considered as an environmentally 
friendly approach14,15.
Scaffolds used as biomaterials for bone regen-
eration should promote cell-cell and cell-material 
interactions, cell adhesion, extracellular matrix 
deposition, diffusion of gases, nutrients, and regula-
tory factors to ensure cell proliferation and differen-
tiation at degradation rate close to regeneration rate 
of bone tissue, without causing an inflammatory 
reaction16. Combination of HAp and organic phase 
(biodegradable polymer) leads to improved biologi-
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cal and mechanical properties of composite materi-
al. HAp provides bioactivity and osteoinductivity, 
while polymer provides mechanical resistance, flex-
ibility, and biodegradability17. Polymers can enable 
porous structure, which promotes bone tissue in-
growth and interactions between an implant and 
natural bone tissue18. One promising candidate as 
polymer matrix in composite scaffolds for bone tis-
sue engineering is biopolymer chitosan (CS). The 
CS is a naturally occurring polysaccharide obtained 
from biopolymer chitin by the deacetylation pro-
cess. Chitin and chitosan are biopolymers obtained 
from crustacean shells of marine source, and they 
are non-toxic, biodegradable, and biocompati-
ble3,15,19. The amino (–NH2) groups in the chitosan 
polymer chain provide anti-bacterial, anti-fungal 
and anti-microbial properties without causing in-
flammatory reaction15,20. Chitosan-based composites 
are commonly used in medical technology as drug 
delivery systems, scaffold-based, wound healing, 
and tissue engineering materials15. Materials ob-
tained from biogenic sources are attracting increas-
ing interest due to remarkable biointeractive surface 
at cell level, better cell attachment and growth, and 
therefore, are more biocompatible than synthetic 
materials3.
Considering all mentioned above, the aim of 
the present work was to synthesize biomimetic hy-
droxyapatite and prepare composite scaffolds based 
on chitosan. The preparation study and biological 
properties of chitosan/hydroxyapatite (CS/HAp) 
scaffolds have been studied, using three different 
biogenic sources for HAp preparation (hen egg-
shells, seashells and cuttlefish bone).
Materials and methods
Preparation of starting materials
Calcium oxide (CaO) obtained from synthetic 
(CaCO3, TTT) and biogenic calcium carbonate from 
hen eggshell, cuttlefish bone (Sepia officinalis L.), 
and seashell (Trachycardium egmontianum L.) was 
used as the source of Ca2+ ions for HAp synthesis. 
To remove the organic matter and obtain CaO from 
hen eggshell (CaO_e), cuttlefish bone (CaO_c), and 
seashell (CaO_s), they were washed, crushed, and 
calcined at 700 °C in air atmosphere for 4 h6,12. Syn-
thetic CaO was obtain by calcination at same condi-
tions as synthetic CaCO3.
Synthesis of hydroxyapatite
HAp was synthesised by wet precipitation 
method by dissolving the appropriate amounts of 
CaO from different sources (prepared as described 
in Preparation of starting materials) in distilled wa-
ter. Ammonium dihydrogen phosphate (NH4H2PO4, 
Lachner) was added into solution to gain Ca/P mo-
lar ratio 1.67 (stoichiometric HAp). Stirring was 
continued for 3 days at 60 °C followed by overnight 
aging at room temperature. The synthesised HAp 
powders from CaO, CaO_e, CaO_c and CaO_s are 
referred to as HAp, HAp_e, HAp_c and HAp_s, re-
spectively. Part of each sample was heat treated at 
1200 °C for 2 h.
Preparation of chitosan-hydroxyapatite 
biocomposite scaffolds
The appropriate amount of chitosan was added 
to 0.40 wt% acetic acid solution to obtain 1.2 wt% 
chitosan solution at ambient temperature. The ap-
propriate amounts of HAp, HAp_e, HAp_c, and 
HAp_s were added to obtain 30 wt% of HAp in chi-
tosan solution, based on a previous study21. The CS/
HAp suspensions were cooled to 4 °C, set in 
moulds, frozen, and kept at –30 °C for 8 h. Further, 
frozen samples were immersed into the neutralisa-
tion medium of 1 M NaOH/ethanol at –30 °C for 24 
h to induce gelation of chitosan. The samples were 
rinsed in ethanol (96 wt%) at –30 °C for 24 h, 
washed with distilled water, frozen, and lyophilized. 
The synthesised chitosan/hydroxyapatite biocom-
posite scaffolds from HAp, HAp_e, HAp_c, and 
HAp_s are referred to as CS/HAp, CS/HAp_e, CS/
HAp_c, and CS/HAp_s, respectively. Schematic di-
agram of composite scaffold preparation is shown 
in Fig 1.
Characterisation of obtained materials
Elemental analysis was performed by ICP-MS 
(ICP-MS PerkinElmer SCIEXT ELANR DRC-e, 
Concord, ON, Canada) according to the manufac-
turer’s protocol. In each batch, ICP-MS accuracy 
was verified with standard reference materials with 
results within the certified concentration range for 
all relevant elements (ICP-MS Complete Standard-
V-ICPMS-71A, Inorganic Ventures, USA). Each 
sample (100 mg) was dissolved in 1 mL of aqueous 
solution of HNO3 (Ultra-Pure, Sigma Aldrich, St. 
Louis, Missouri, SAD), and the solution volume 
was increased up to 10 mL with ultrapure water.
The final pH of precipitated suspensions was 
measured on Schott CG 842 pH-meter using Blue-
Line 14 electrode with precision of 0.01 at room 
temperature.
Phase analyses of obtained calcium oxides 
were done using X-ray diffraction analysis (XRD) 
performed on Shimadzu XRD-6000 (Shimadzu, 
XRD-6000, Duisburg, Germany) diffractometer 
with Cu Kα (1.5406 Å) radiation operated at 40 kV 
and 30 mA, in the range 35°–70°, at a step size of 
0.02°, and exposure of 0.6 s. Phase analysis of 
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as-prepared and heat-treated HAp powders, mixed 
with 5 wt% of polycrystalline silicon standard 
(NIST SRN 640e, Sigma Aldrich), was performed 
using X-ray diffraction analysis (XRD) in the range 
of 20°–70°, at a step size of 0.02°, and exposure of 
3 s. The software DIFFRAC.SUITE TOPAS V.5.0. 
(Bruker, Karlsruhe, Germany) with the fundamental 
parameters approach was employed for Rietveld re-
finements. The structural parameters of HAp ob-
tained by Veselinović et al.22, β-tricalcium phos-
phate by Yashima et al.23, and α-tricalcium phosphate 
by Mathew et al.24, have been used as the initial 
values in the refinements. The crystallite size of 
HAp along the c- and a-axis were calculated apply-
ing Scherrer’s approximation, measuring the full 
width at half maximum (FWHM) of reflection. The 
weighted profile R-factor (Rwp) was used to assess 
the goodness-of-fit of the Rietveld refinement, 
while results with Rwp < 11 % and Rexp < 3 % were 
considered to be acceptable.
The Fourier transform infrared spectra (FTIR) 
of as-prepared HAp powders and CS/HAp biocom-
posite scaffolds were recorded by attenuated total 
reflectance (ATR) spectrometer for solids with dia-
mond crystal (Bruker, Vertex 70, Ettlingen, Germa-
ny) at 20 °C, over the spectral range of 4000–400 
cm–1, with 32 scans and 4 cm–1 of resolution.
The morphology of prepared CS/HAp biocom-
posite scaffolds was analysed by scanning electron 
microscopy (SEM, TESCAN, Vega3 EasyProbe, 
Kohoutovice, Czech Republic) at electron beam en-
ergy of 11 keV. Scaffolds were coated with plasma 
of gold and palladium for 90 s. Obtained SEM im-
ages and ImageJ software (ImageJ2, Madison, Wis-
consin, USA) were used to determine diameter of 
350 pores of different CS/HAp scaffolds. The re-
sults are shown as pore density (%) of each pore 
range in relation to the total number of measured 
pores.
Porosity of the scaffolds was evaluated by Ar-
chimedes’ principle, immersing each scaffold in 
ethanol (ρ = 0.789 g cm–3) at room temperature. The 
scaffolds porosity (%) was calculated as the pore 
volume (Vpore) fraction within the total volume of 










The samples were cut with biopsy puncher into 
cylindrical pieces of 6 mm diameter (D) from previ-
ously prepared scaffold with uniform thickness (H) 
of ~1 mm. The dry samples (n = 5) were initially 
weighed (Wd). After immersion in ethanol under 
vacuum atmosphere, excess liquid was removed 
with the humid blanket, and samples were weighed 
again (We). The pore volume was calculated accord-
ing to Eq. (2):
 e dpore 
ethanol
  W WV
ρ
−
=   (2)
F i g .  1  – Schematic diagram of the synthesis of composite chitosan/hydroxyapatite scaffolds 
obtained from eggshell, cuttlefish bone, and seashell
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The density of cylindrically-shaped scaffold is 













Prepared scaffolds were cut into cylindrical 
pieces of 6 mm diameter and ~1 mm height, steril-
ised in 96 % ethanol for 24 h. After sterilisation, 
scaffolds were washed 3 times with phosphate-buff-
ered saline (PBS) solution (Gibco – Thermo Fisher 
Scientific, Waltham, Massachusetts, USA), and left 
in Dulbecco’s modified Eagle’s culture medium 
(DMEM) – high glucose (Sigma- Aldrich, St. Lou-
is, Missouri, USA) supplemented with 10 % foetal 
bovine serum (Capricorn Scientific, Ebsdorfergr-
und, Hessen, Germany) and 1 % penicillin/strepto-
mycin (Lonza, Basel Switzerland) for 24 h at 4 °C. 
The following day, scaffolds were transported into 
polystyrene 96-well plates with hydrophobic sur-
face (Corning – Sigma Aldrich).
The human embryonic kidney 293 (HEK 293) 
cells were seeded on each scaffold in a concentra-
tion 0.5 · 105 cells/200 µL of medium per well. Cell 
suspension was added on each scaffold, and incu-
bated for 30 min in the incubator to allow cell at-
tachment and migration inside the scaffold. Follow-
ing the incubation period, the medium was added to 
a final volume of 200 µL per well. Each experiment 
was performed in triplicate. Blanks for both assays 
were included as well. The cells were kept in a 5 % 
CO2 humidified atmosphere at 37 °C.
Cytotoxicity evaluation by MTT assay
Evaluation of potential cytotoxicity was ob-
tained by staining with (3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT, 
Sigma-Aldrich, St. Louis, Missouri, USA), and col-
orimetric detection at 560 nm using microplate 
reader (GlowMax-Multi, PromegaMadison, Wis-
consin, USA) after 1 and 3 days of cell culture. The 
medium was removed, and 200 µL of MTT solution 
diluted in medium (0.5 mg mL–1) was added to each 
well. Following the incubation period of 3 h at 
37 °C, MTT solution was aspirated and 150 μL of 
DMSO (Sigma-Aldrich, St. Louis, Missouri, USA) 
added to each well. Following the 15 min incuba-
tion needed for dissolution of formazan crystals, 
100 µL of solution was transferred into clean 
96-plate in order to read absorbance.
Quantitative detection of cell viability by Live  
and Dead Cell assay
The percentage of live and dead cell population 
was determined by fluorescent detection using Live 
and Dead kit (Abcam, Cambridge, UK) after 1 and 
7 days of cell culture. In order to collect cells from 
each scaffold, the medium was removed; scaffolds 
were washed with PBS followed by trypsinisation 
(Sigma-Aldrich, St. Louis, Missouri, USA) and 
neutralisation with the medium. Samples were cen-
trifuged at 300 x g for 5 min, and the supernatant 
was removed. The cell pallet was washed with PBS 
and incubated with 200 µL of the stain diluted 
1 000 x in PBS. After 10 min incubation in the dark, 
solution was transferred into black opaque 96-well 
plates (Corning – Sigma Aldrich, St. Louis, Missou-
ri, USA) and analysed on microplate reader (Glow-
Max-Multi, PromegaMadison, Wisconsin, USA) 
using fluorescent filters (excitation 490 nm, emis-
sion 510–570 nm).
Statistical analysis
MTT experiments were performed in triplicate 
(n = 3), and Live and Dead assay in quadruplicate 
(n = 4). All data were expressed as mean ± standard 
deviation. Statistical analysis was performed using 
one-way ANOVA test followed by a post-hoc test to 
evaluate the statistical significance between groups. 
A value of p < 0.05 was considered statistically sig-
nificant, and p < 0.01 was considered highly statis-
tically significant.
Results and discussion
Pharmacologics and biologics were used in 
combination with calcium phosphate ceramics 
(CaP) to increase bone regeneration. However, the 
use of growth factors might result in negative side 
effects, such as unwanted ectopic bone formation. 
The natural bone mineral is multi-substituted calci-
um-deficient apatite, which includes low concentra-
tions of different ions, such as Mg2+, Sr2+, Na+, 
CO3
2–, Fe3+, etc. Nowadays, the interest is turning to 
biomimetic synthetic apatite, where biogenic sourc-
es are used to produce multi-substituted HAp as an 
alternative and potentially safer strategy3,25,26. The 
trace elements are essential during bone tissue re-
generation as they increase proliferation and differ-
entiation of osteoblast cells, and decrease osteoclast 
cells activity26. Moreover, the presence of trace ele-
ments results in higher dissolution rate compared to 
stoichiometric hydroxyapatite. That leads to higher 
concentration of released ions that are essential for 
bone regeneration process27. According to in vivo 
studies obtained by Lee et al.28, higher rate of bone 
formation was measured in defect filled with HAp 
obtained from eggshells compared to defect filled 
with HAp obtained from seashells. Different bone 
formation can be the result of different element 
composition of HAp obtained from different sourc-
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es. Furthermore, recently developed interest for 
nanotechnology in many fields is producing inter-
esting and imminent applications for nano-hydroxy-
apatite in orthopaedics29, dentistry30 and maxillofa-
cial31 surgery. The aim of this study was the 
synthesis of multi-substituted HAp, and to deter-
mine which of the biogenic sources and associated 
trace elements leads to enhanced biological perfor-
mance. The HAp was prepared from biogenic waste 
materials that are available in large quantities in na-
ture. Hen eggshell, seashell, and cuttlefish bone are 
mainly composed of calcium carbonate (~95 %), 
while the rest is organic component and mineral 
salts32. To mimic collagen type I in natural bone tis-
sue, biopolymer chitosan as polymer matrix was 
used.
XRD patterns of calcium oxides
After the heat treatment of synthetic and bio-
genic calcium carbonates (CaCO3), the XRD pat-
terns (Fig. 2a) show characteristic peaks for CaO 
(ICDD 82-1691), without characteristic peaks of 
aragonite and calcite polymorphs. Under heating, 
CaCO3 decomposes to calcium oxide (CaO) (and 
carbonate dioxide), which was further dissolved in 
distilled water, producing calcium hydroxide 
(Ca(OH)2)
25,26. To obtain HAp, appropriate amount 
of NH4H2PO4 was added to Ca(OH)2 and following 
reaction occurred6:
 10Ca(OH)2 + 6NH4H2PO4 → Ca10(PO4)6(OH)2 +  
 + 6NH3 + 18H2O (1)
FTIR analysis
FTIR spectra (Fig. 2b) of all as-prepared pow-
ders (HAp, HAp_e, HAp_c, and HAp_s) is shown 
in the range 400–1550 cm–1, while at the wave num-
bers >1550 cm–1 significant bands were not detect-
ed. Typical bands of phosphate (PO4
3–) group at 
1026 and 1091 cm–1 are attributed to asymmetric 
stretching vibration of P–O, bands at 561 cm–1 and 
601 cm–1 to asymmetric bending vibrations of 
O–P–O and 961 cm–1 band associated to symmetric 
stretching vibration of P–O, which can be assigned 
to HAp phase. The absorption bending vibrations of 
O–H observed around 632 cm–1 is characteristic for 
structural OH– group in HAp crystal34,35. Weak ab-
sorption bands characteristic for carbonate (CO3
2–) 
group at 870 (out of plane bending), 1416 and 1455 
cm–1 (asymmetric stretching) indicate that tetrahe-
dral PO4
3– sites in the HAp lattice are partially re-
placed by CO3
2– (B-type of substitution) typical for 
biological apatite36,37. As HAp powders are synthe-
sised from CaO, CO3
2– substitution was expected 
due to the high reactivity of the initial component 
and the presence of CO2 in the process of synthesis 
at atmosphere conditions, as previously described 
by Goloshchapov et al.32 The CO3-substitution in 
HAp lattice enhances bioresorption and therefore 
osteogenic performance of synthetic material32. As 
reported by Kumar et al.34, CO3
2– ions are most 
abundant ions in natural bone mineral with weight 
ratio in the range 4–8 wt%. In the early stage of 
bone maturation, B-type substitution is dominant, 
while as humans grow older, A-type substitution in-
creases34.
Chemical composition of as-prepared powders
The chemical composition of HAp powders 
was determined by ICP-MS analysis (Table 1). In 
all prepared samples from biogenic source Sr2+, 
Mg2+ and Na+ ions, which are typical trace elements 
in natural bone mineral, were detected. Compared 
F i g .  2  – XRD patterns (a) of heat-treated calcite (synthetic, 
CaO; eggshell, CaO_e; cuttlefish bone, CaO_e; seashell, 
CaO_s). Characteristic CaO (ICDD 82-1691) diffraction max-
ima are depicted as (°). FTIR spectra (b) of as-prepared HAp 
synthesised from prepared calcium oxides.
(a)
(b)
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to HAp obtained from biogenic source (HAp_e, 
HAp_c, and HAp_s), control powder (HAp) pre-
pared from synthetic CaO, had significantly lower 
content of strontium (0.01 mol%) and sodium ions 
(0.00 mol%), while comparable content of magne-
sium (0.40 mol%) ions. The sodium (0.74 mol%) 
and strontium (0.49 mol%) contents were signifi-
cantly higher in the case of HAp_c, while higher 
magnesium content (1.40 mol%) was measured in 
HAp_e. The Sr2+, Mg2+ and Na+ content were sig-
nificantly lower in the case of HAp_s compared to 
HAp_c and HAp_e. The higher magnesium content 
in HAp obtained from hen eggshells is not surpris-
ing since the hen eggshell is composed of CaCO3, 
organic component, and ~1 % magnesium carbon-
ate, as previously described by Akram et al.10 These 
results are in accordance with the work of Lee et 
al.28, who observed higher concentration of Mg ions 
in HAp obtained from eggshell compared to HAp 
obtained from seashells. The aragonite structure of 
cuttlefish bone is stabilised with strontium ions38,39 
that results in higher strontium content in HAp_c 
compared to HAp_e and HAp_s. Obtained results 
provide additional support for results obtained by 
previous studies confirming that by using biogenic 
sources, the multi-substituted hydroxyapatite can be 
obtained.
Sodium (Na+) and magnesium (Mg2+) ions are 
highly important in the early stage of bone mineral-
isation, whereas the lack of these ions may result in 
bone fragility34. Previous studies have shown that 
substituting CaP materials with Mg2+ improved den-
sification as well as osteoblastic cellular attachment, 
proliferation, and alkaline phosphatase (ALP) pro-
duction26. In vivo studies obtained by Landi et al.40 
showed greater osteogenic properties of CaPs sub-
stituted with Mg2+ compared to non-substituted sys-
tem. Further, magnesium possesses antibacterial 
and antitumor properties reducing the risk of in-
flammatory reaction41. Strontium plays a crucial 
role in bone formation by increasing osteoblast ac-
tivity through stimulating the calcium sensing re-
ceptor, while reducing bone resorption by inhibiting 
the formation of osteoclasts26,42. Compared to other 
scaffold materials that are combined with growth 
factors, the scaffolds composed of hydroxyapatite 
substituted with trace elements can achieve long-
term release of ions that promote bone repair, and 
show good bioactivity and osteoinductivity in terms 
of proliferation, cell viability, and morphology42.
As expected, HAps synthesised from biogenic 
sources have lower Ca/P ratio (Table 1) than stoi-
chiometric HAp with Ca/P molar ratio 1.67. This 
can be due to trace elements present in HAp struc-
ture as determined by ICP-MS method. Obtained 
results are in good agreement with bioapatite that is 
so-called calcium-deficient hydroxyapatite with 
Ca/P molar ratio ~1.543,44. Contrary to expectations, 
the HAp obtained from synthetic CaO had Ca/P ra-
tio 2.08, although the stoichiometric Ca/P ratio was 
expected. The reason for this rather contradictory 
result is still not entirely clear, but there are two 
possible explanations for this outcome. Comparing 
the experimental diffraction pattern (Fig. 3) to 
JCPDS standards, the crystalline phase is ascribed 
to HAp (JCPDS 09-0432), while Rietveld refine-
ment studies demonstrated presence of amorphous 
calcium phosphate (ACP) phase as well (Table 1). 
The ACP can have Ca/P molar ration in the range 
1.2–2.2, depending on the synthesis conditions and 
used precursors43. Further, the higher Ca/P molar ra-
tio can be the result of higher calcium content and 
lower phosphate content as result of B-type substi-
tution, as previously explained by FTIR analysis.
XRD patterns of as-prepared powders and 
Rietveld refinements
Comparison of the XRD results to JCPDS HAp 
standard, confirmed the formation of crystalline 
hexagonal structure in the space group P63/m. Riet-
veld refinement studies have confirmed the pres-
ence of ACP in all as-prepared samples. The weight 
percentage of ACP (Table 1) differed between the 
samples, 14.41 wt% was determined in HAp, 24.48 
wt% in HAp_e, 11.38 wt% in HAp_c, 35.96 wt% in 
HAp_s, respectively. The final pH of all precipitat-
ed solutions at room temperature was 10.41 ± 0.06, 
and it favoured HAp and ACP precipitation45. In the 
literature, different estimates of the ACP content in 
bone mineral can be found, in the range 1–30 % of 






Sr Na Mg Al Fe HAp ACP
HAp_s 0.20 0.34 0.26 0.07 0.07 1.58 64.04 35.96
HAp_c 0.49 0.74 0.60 0.06 0.08 1.48 88.62 11.38
HAp_e 0.12 0.13 1.40 0.05 0.06 1.55 75.52 24.48
HAp 0.01 0.00 0.40 0.05 0.02 2.08 85.59 14.41
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the total mineral mass, while the rest is poorly crys-
talline calcium deficient hydroxyapatite substituted 
with various ions45.
The Rietveld refinement studies revealed no 
significant difference between the lattice parameters 
of HAp obtained from different sources (Table 2), 
and they were almost identical to lattice parameters 
of HAp standard JCPDS 09-0432. It can be assumed 
that the presence of trace elements had no influence 
on the cell structure of HAp. The average crystallite 
size (L), calculated using Scherrer equation, was 
12.21 nm for HAp, 10.99 nm for HAp_e, 13.03 nm 
for HAp_c, and 13.39 nm for HAp_s. All prepared 
HAp powders could be considered as nanostruc-
tured, and the surface of nanostructured materials 
plays an important role in cell adhesion, migration, 
and extracellular matrix production46.
XRD patterns of heat-treated powders and 
Rietveld refinements
XRD patterns of heat-treated powders at 1200 °C 
are presented in Fig. 4. The synthesised HAp, 
HAp_e, HAp_c, and HAp_s powders after heat 
treatment were referred to as HAp_h, HAp_e_h, 
HAp_c_h, and HAp_s_h, respectively. In compari-
son to XRD patterns of as-prepared powders, the 
diffraction peaks of heat-treated powders had sharp-
ened, indicating an increase in crystallinity due to 
the heat treatment. The phase composition of sam-
ples after heat treatment is given in Table 3. HAp_h, 
HAp_c_h, and HAp_s_h were composed of HAp 
(JCPDS 09-0432), β-TCP (JCPDS 09-0169), α-TCP 
(JCPDS 09-0348) and ACP, while in HAp_e_h 
powder α-TCP was not detected. As previously de-
scribed by Liao et al.47, XRD patterns, after heat 
treatment of hydroxyapatite in range 1000 – 1350 °C, 
showed characteristic peaks of stoichiometric HAp. 
F i g .  3  – Rietveld analysis pattern of powder diffraction data 
for as-prepared CaP powders obtained from different biogenic 
sources. The open circles are experimental data and the solid 
lines are calculated intensities. The difference between the ex-
perimental and calculated intensities is plotted below the pro-
file (Rwp < 11 %; Rexp < 3 %). Bragg positions of hydroxyapatite 
and silicon (standard) are marked below each pattern.




V (Å3) a = b (Å) c (Å) L (nm)
HAp_s 530.084 9.4304265 6.8825875 13.93
HAp_c 529.946 9.4298413 6.8816424 13.03
HAp_e 529.956 9.4332978 6.8767361 10.99
HAp 529.730 9.4284543 6.8808578 12.21
Ta b l e  3  – Quantitative analysis of phases in heat-treated 




HAp β-TCP α-TCP ACP
HAp_s_h 58.62 4.31 14.52 22.55
HAp_c_h 74.09 17.38 4.69 3.84
HAp_e_h 42.65 37.46 – 19.89
HAp_h 68.32 12.35 18.73 0.60
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However, calcium deficient HAp with trace ele-
ments in its lattice structure can reduce the tempera-
ture of phase transformation to β-TCP and α-TCP 
due to disrupted crystal lattice stability47. The 
HAp_e, HAp_c, and HAp_s obtained from biogenic 
source were composed of calcium deficient HAp as 
Ca/P ratio was lower than 1.67, and partial phase 
transformation to β-TCP and α-TCP was expected. 
The HAp_e_h was composed of HAp and β-TCP 
without precipitation of α-TCP. Stipniece et al.48 re-
ported that Mg2+ ions promote the thermal conver-
sion of HAp to β-TCP, i.e., those ions prefer to sub-
stitute and stabilise β-TCP crystal structure. It can 
be supposed that high concentration of Mg2+ ions in 
HAp_e is the reason why HAp to α-TCP transfor-
mation had not been observed. Similar effect was 
detected in HAp_c_h, where higher amount of pre-
cipitated β-TCP and lower amount of α-TCP was 
detected compared to HAp_h and HAp_s_h due to 
0.60 mol% substitution with Mg2+ ion prior to heat 
treatment.
Morphology of CS/HAp scaffolds
The microstructures of CS/HAp, CS/HAp_e, 
CS/HAp_c, and CS/HAp_s shown in Fig. 5a reveal 
highly porous structure with sphere-like HAp parti-
cles homogeneously dispersed in chitosan matrix. 
In natural bone tissue, the mineral is mainly calci-
um deficient carbonate HAp substituted with trace 
elements with plate-like morphology. However, 
synthetic HAp can have various nanostructures like 
sphere, rod, plate, flake, flower, etc.6
The determined pore volume fraction was 
57.02 ± 0.01 % in CS/HAp, 60.81 ± 0.09 % in CS/
HAp_e, 60.24 ± 0.07 % in CS/HAp_c, 58.41 ± 0.04 % 
in CS/HAp_s scaffold, respectively. Highly porous 
structure is an essential parameter for oxygen, nutri-
ents and metabolic waste diffusion, and enables tis-
sue ingrowth and contributes to the creation of per-
manent interactions between a tissue and the 
implant18,49. The analysis of porosity and pore size 
distribution revealed no significant differences be-
tween the samples. The distribution of pore size, 
shown in Fig. 5b, ranged from ~35 to ~350 μm in 
the CS/HAp_e, CS/HAp_c, and CS/HAp_s scaf-
folds, and from ~50 to ~400 μm in CS/HAp scaf-
fold. It has been suggested that the pore size must 
be large enough to allow migration of cells, but 
small enough to allow the binding of cells to the 
scaffold. Porous polymer scaffolds with a pore size 
of 100–500 μm, combined with hydroxyapatite, 
were found to be optimal scaffolds for bone-tissue 
engineering49. It can be assumed that only different 
trace elements present in HAp lattice would influ-
ence biological properties of obtained scaffolds.
FTIR analysis of CS/HAp scaffolds
FTIR spectra (Fig. 6) of composite scaffolds 
(CS/HAp, CS/HAp_e, CS/HAp_c, and CS/HAp_s) 
and control (CS) is shown in the range 400–1750 cm–1, 
F i g .  4  – Rietveld analysis pattern of powder diffraction data 
for heat-treated CaP powders obtained from different biogenic 
sources. The open circles are experimental data and the solid 
lines are calculated intensities. The difference between the ex-
perimental and calculated intensities is plotted below the pro-
file (Rwp < 11 %; Rexp < 3 %). Bragg positions of hydroxyapa-
tite, β-tricalcium phosphate, α-tricalcium phosphate and silicon 
(standard) are marked below each pattern.
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as at the wave numbers >1750 cm–1 significant 
bands were not found. Typical bands of chitosan 
groups were found at 1654 cm–1, corresponding to 
amid I (carbonyl band of amid), at 1568 cm–1 at-
tributed to amid II (amino band of amid), 1421 cm–1 
and 1323 cm–1 that correspond to the vibrations of 
OH and CH in the ring, 1377 cm–1 to CH3 in amide 
group, and range 1025 – 1151 cm–1 to C–O–C in 
glycosidic linkage50. Along with characteristic bands 
for chitosan, typical bands for HAp were found at 
564 cm–1, 600 cm–1 and 1028 cm–1 corresponding to 
PO4
3–, and at 631 cm–1 corresponding to OH– group.
Biological evaluation of CS/HAp scaffolds
The biological evaluation of CS/HAp scaffolds 
has been performed on the HEK 293 cells to deter-
mine cytotoxicity and cell viability performance. 
F i g .  5  – Microscopic imaging (a) and pore size distribution (b) of prepared composite scaffolds obtained from different biogenic 
sources. Scale bar: 200 and 20 μm.
                                         (a)                                                                               (b)
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Mitochondria are essential metabolic organelles of 
cells, and their activity can be a direct indicator of 
cell viability and proliferation. MTT assay is used 
to assess the mitochondrial activity of cells. The vi-
ability of HEK 293 cells cultured on CS/HAp, CS/
HAp_e, CS/HAp_c, and CS/HAp_s scaffolds was 
determined by MTT assay (Fig. 7a). The cells seed-
ed on prepared scaffolds showed no significant dif-
ference in cell viability after 1 day of cell culture. 
Following the 3-day incubation period, the cell via-
bility enhanced with significant difference for the 
cells seeded on CS/HAp_e, CS/HAp_c, and CS/
HAp_s scaffolds, respectively. Meanwhile, the cells 
seeded on CS/HAp showed a lack of significant in-
crease in cell viability. The significant increase in 
cell viability provides additional support for using 
biogenic sources as precursors to obtain scaffolds 
for bone regeneration.
The Live/dead assay was determined after 1 
and 7 days of cell culture, and is shown in Fig. 7b. 
The composite scaffolds obtained from chitosan and 
HAp derived from biogenic sources (CS/HAp_e, 
CS/HAp_c an CS/HAp_s) displayed enhanced per-
cent of live cells compared to the scaffold obtained 
from chitosan and synthetic hydroxyapatite (CS/
HAp). The CS/HAp_e and CS/HAp_c showed 
greater percent of live cells after 7 days of cell culture 
compared to CS/HAp and CS/HAp_s, respectively.
Our results are in accordance with the work of 
Kim et al.51 suggesting that cell proliferation is sig-
nificantly higher for HAp obtained from cuttlefish 
bone compared to synthetic HAp. Similar findings 
are reported by Lee et al.28 demonstrating better bi-
ological performance of HAp obtained from egg-
shells compared to seashells. As explained, the 
higher concentration of Mg2+ ions in HAp structure 
obtained from eggshells might be related to the 
higher bone regeneration in comparison with HAp 
obtained from seashells. The Mg2+ ions are related 
to the early stage of bone formation and metabo-
lism. Both in vitro and in vivo studies show greater 
bone formation of materials enriched with Mg2+ 
ions37,50. Greater cell proliferation of the CS/HAp_c 
scaffold can be related to the higher content of Sr2+ 
ion as previously described by Braux et al. 52 and 
Neves et al.53 The Sr2+ ions are used in osteoporosis 
treatment, and stimulate bone formation and de-
crease bone resorption in vivo. Lower cell viability 
on CS/HAp_s can be the result of a significantly 
lower trace element concentration of HAp obtained 
from seashells compared to HAp obtained from 
eggshells and cuttlefish bone.
Conclusion
Composite scaffolds based on biodegradable 
polymers and bioactive ceramics are promising ma-
terials for bone-tissue regeneration applications. 
F i g .  6  – FTIR spectra of prepared composite scaffolds ob-
tained from different biogenic sources. Chitosan 
(CS) scaffold was used as a control.
F i g .  7  – Cytotoxicity (a) of CS/HAp scaffolds obtained from 
different biogenic sources. The viability of human embryonic 
kidney 293 cells at 1 and 3 days of cell culture expressed by the 
absorbance at 560 nm. Quantification (%) of live cells (b) on 
prepared scaffolds (CS/HAp, CS/HAp_e, CS/HAp_c, CS/
HAp_e) determined by Live/dead assay. The significant differ-
ence between two groups: * (p < 0.05), ** (p < 0.01).
(a)
(b)
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The incorporation of metal ions into a hydroxyapa-
tite structure is a promising pathway to increase the 
biological properties of the scaffolds. Using biogen-
ic sources, such as eggshells and cuttlefish bone, to 
prepare multi-substituted HAp, can be considered 
an environmentally friendly and economically via-
ble approach. Positive influence of Mg2+ and Sr2+ 
ions, present in eggshell and cuttlefish bone, on cell 
viability has been observed. However, further stud-
ies involving swelling and biodegradation assay at 
simulated biological conditions, and seeding of 
stem or preosteoblastic lineage need to be per-
formed in order to confirm CS/HAp_e and CS/
HAp_c scaffolds as potential bone-tissue engineer-
ing materials.
ACKnOWLEDgMEnTS
This work has been supported by Croatian Sci-
ence Foundation under the project IP-2014-09-
3752.
L i t e r a t u r e
1. Mondal, S., Pal, U., Dey, A., Natural origin hydroxyapatite 
scaffold as potential bone tissue engineering substitute, 
Ceram. Int. 42 (2016) 18338.
doi: https://doi.org/10.1016/j.ceramint.2016.08.165
2. Lilley, K. J., gbureck, U., Wright, A. J., Farrar, D. F., Bar-
ralet, J. E., Cement from nanocrystalline hydroxyapatite: 
Effect of calcium phosphate ratio, J. Mater. Sci: Mater. 
Med. 16 (2005) 1185.
doi: https://doi.org/10.1007/s10856-005-4727-2
3. Lalzawmliana, V., Anand, A., Mukherjee, P., Chaudhuri, S., 
Kundu, B., nandi, S. K., Thakur, n. L., Marine organisms as 
a source of natural matrix for bone tissue engineering, 
Ceram. Int. 45 (2019) 1469.
doi: https://doi.org/10.1016/j.ceramint.2018.10.108
4. Cortesini, R., Stem cells, tissue engineering and organogen-
esis in transplantation, Transpl. Immunol. 15 (2005) 81.
doi: https://doi.org/10.1016/j.trim.2005.09.013
5. Sato, K., Mechanism of hydroxyapatite mineralization in 
biological systems, J. Ceram. Soc. Jpn. 115 (2007) 124.
doi: https://doi.org/10.2109/jcersj.115.124
6. Sadat-Shojai, M., Khorasani, M. T., Dinpanah-Khoshdargi, 
E., Jamshidi, A., Synthesis methods for nanosized hydroxy-
apatite with diverse structures, Acta. Biomater. 9 (2013) 
7591.
doi: https://doi.org/10.1016/j.actbio.2013.04.012
7. Zhou, H., Lee, J., Nanoscale hydroxyapatite particles for 
bone tissue engineering, Acta. Biomater. 7 (2011) 2769.
doi: https://doi.org/10.1016/j.actbio.2011.03.019
8. Legeros, R. Z., Biodegradation and bioresorption of cal-
cium phosphate ceramics, Clin. Mater. 14 (2013) 65.
doi: https://doi.org/10.1016/0267-6605(93)90049-D
9. Ho, W. F., Hsu, H. C., Hsu, S. K., Hung, C. W., Wu, S. C., 
Calcium phosphate bioceramics synthesized from eggshell 
powders through a solid state reaction, Ceram. Int. 39 
(2013) 6467.
doi: https://doi.org/10.1016/j.ceramint.2013.01.076
10. Akram, M., Ahmed, R., Shakir, I., Ibrahim, W. A. W., Hus-
sain R., Extracting hydroxyapatite and its precursors from 
natural resources, J. Mater. Sci. 49 (2014) 1461.
doi: https://doi.org/10.1007/s10853-013-7864-x
11. Lin, K., Zhou, Y., Zhou, Y., Qu, H., Chen, F., Zhu, Y., Chang, 
J., Biomimetic hydroxyapatite porous microspheres with 
co-substituted essential trace elements: Surfactant-free 
hydrothermal synthesis, enhanced degradation and drug 
release, J. Mater. Chem. 21 (2011) 16558.
doi: https://doi.org/10.1039/C1JM12514A
12. Kamalanathan, P., Ramesh, S., Bang, L. T., niakan, A., Tan, 
C. Y., Purbolaksono, J., Chandran, H., Teng, W. D., Synthe-
sis and sintering of hydroxyapatite derived from eggshells 
as a calcium precursor, Ceram. Inter. 40 (2014) 16349.
doi: https://doi.org/10.1016/j.ceramint.2014.07.074
13. Boutinguiza, M., Pou, J., Comesaña, R., Lusquiños, F., de 
Carlos, A. León, B., Biological hydroxyapatite obtained 
from fish bones, Mater. Sci. Eng. C 32 (2012) 478.
doi: https://doi.org/10.1016/j.msec.2011.11.021
14. Suresh Kumar, g., girija, E. K., Flower-like hydroxyapatite 
nanostructure obtained from eggshell: A candidate for bio-
medical applications, Ceram. Inter. 39 (2013) 8293.
doi: https://doi.org/10.1016/j.ceramint.2013.03.099
15. Trakoolwannachai, V., Kheolamai, P., Ummartyotin, S., 
Development of HAp from eggshell waste and a chitosan 
based composite: In vitro behavior of human osteoblast-like 
cell (Saos-2) cultures, Int. J. Biol. Macromol. 134 (2019) 
557.
doi: https://doi.org/10.1016/j.ijbiomac.2019.05.004
16. Rodríguez-Vázquez, M., Vega-Ruiz, B., Ramos-Zúñiga, R., 
Saldaña-Koppel, D. A., Quiñones-Olvera, L. F., Chitosan 
and its potential use as a scaffold for tissue engineering in 
regenerative medicine, Biomed. Res. Int. 2015 (2015) 
821279.
doi: https://doi.org/10.1155/2015/821279
17. Szcześ, A., Hołysz, L., Chibowski, E., Synthesis of hydroxy-
apatite for biomedical applications, Adv. Colloid. Interface. 
Sci. 249 (2017) 321.
doi: https://doi.org/10.1016/j.cis.2017.04.007
18. Sobczak – Kupiec, A., Pluta, K., Drabczyk, A., Włos, M., 
Tyliszczak, B., Synthesis and characterization of ceramic – 
polymer composites containing bioactive synthetic 
hydroxyapatite for biomedical applications, Ceram. Inter. 
44 (2018) 13630.
doi: https://doi.org/10.1016/j.ceramint.2018.04.199
19. Rezwan, K., Chen, Q. Z., Blaker, J. J., Boccaccini, A. R., 
Biodegradable and bioactive porous polymer/inorganic 
composite scaffolds for bone tissue engineering, Biomateri-
als 27 (2006) 3413.
doi: https://doi.org/10.1016/j.biomaterials.2006.01.039
20. Pillai, C. K. S., Paul, W., Sharma, C. P., Chitin and chitosan 
polymers: Chemistry, solubility and fiber formation, Prog. 
Polym. Sci. 34 (2009) 641.
doi: https://doi.org/10.1016/j.progpolymsci.2009.04.001
21. Rogina, A., Rico, P., Gallego Ferrer, G., Ivanković, M., 
Ivanković, H., In Situ hydroxyapatite content affects the 
cell differentiation on porous chitosan/ hydroxyapatite scaf-
folds, Ann. Biomed. Eng. 44 (2015) 1107.
doi: https://doi.org/10.1007/s10439-015-1418-0
22. Veselinović, Lj., Karanović, Lj., Stojanović, Z., Bračko, I., 
Marković, S., Ignjatović, N. Uskoković, D., Crystal struc-
ture of cobalt-substituted calcium hydroxyapatite nanopow-
ders prepared by hydrothermal processing, J. Appl. Cryst. 
43 (2010) 320.
doi: https://doi.org/10.1107/S0021889809051395
70 A. Ressler et al., From Bio-waste to Bone Substitute…, Chem. Biochem. Eng. Q., 34 (2) 59–71 (2020)
23. Yashima, M., Sakai, A., Kamiyama, T., Hoshikawa, A., 
Crystal structure analysis of β-tricalcium phosphate 
Ca3(PO4)2 by neutron powder diffraction, J. Solid. State. 
Chem. 175 (2003) 272.
doi: https://doi.org/10.1016/S0022-4596(03)00279-2
24. Mathew, M., Brown, W. E., Schroeder, L. W., Dickens, B., 
The crystal structure of alpha-Ca3(PO4)2, Acta Crystallogr. 
B 33 (1977) 1325.
doi: https://doi.org/10.1107/S0567740877006037
25. Salma-Ancane, K., Stipniece, L., Irbe, Z., Effect of biogenic 
and synthetic starting materials on the structure of hydroxy-
apatite bioceramics, Ceram. Inter. 42 (2016) 9504.
doi: https://doi.org/10.1016/j.ceramint.2016.03.028
26. Bose, S., Fielding, g., Tarafder, S., Bandyopadhyay, A., 
Understanding of dopant-induced osteogenesis and angio-
genesis in calcium phosphate ceramics, Trends Biotechnol. 
31 (2013) 594.
doi: https://doi.org/10.1016/j.tibtech.2013.06.005
27. Ressler, A., Cvetnić, M., Antunović, M., Marijanović, I., 
Ivanković, M., Ivanković, H., Strontium substituted biomi-
metic calcium phosphate system derived from cuttlefish 
bone, J. Biomed. Mater. Res. 108B (2020) 1697-1709.
doi: https://doi.org/10.1002/jbm.b.34515
28. Lee, S. W., Balázsi, C., Balázsi, K., Seo, D. H., Kim, H. S., 
Kim, C. H., Kim, S. g., Comparative study of hydroxyapa-
tite prepared from seashells and eggshells as a bone graft 
material, J. Tissue. Eng. Regen. Med. 11 (2014) 113.
doi: https://doi.org/10.1007/s13770-014-0056-1
29. Song, Y., Wu, H., gao, Y., Li, J., Lin, K., Liu, B., Lei, X., 
Cheng, P., Zhang, S., Wang, Y., Sun, J., Bi, L., Pei, g., Zinc 
silicate/nano-hydroxyapatite/collagen scaffolds promote 
angiogenesis and bone regeneration via the p38 MAPK 
pathway in activated monocytes, ACS Appl. Mater. Inter-
faces 12 (2020) 16058.
doi: https://doi.org/10.1021/acsami.0c00470
30. Scribante, A., Dermenaki Farahani, M. R., Marino, g., 
Matera, C., Rodriguez, Y., Baena, R., Lanteri, V., Butera, 
A., Biomimetic effect of nano-hydroxyapatite in demineral-
ized enamel before orthodontic bonding of brackets and 
attachments: Visual, adhesion strength, and hardness in in 
vitro tests, Biomed. Res. Int. 2020 (2020) 2314.
doi: https://doi.org/10.1155/2020/6747498
31. Khaled, H., Atef, M., Hakam, M., Maxillary sinus floor ele-
vation using hydroxyapatite nano particles vs tenting tech-
nique with simultaneous implant placement: A randomized 
clinical trial, Clin. Implant. Dent. Relat. Res. 21(6) (2019) 
1241.
doi: https://doi.org/10.1111/cid.12859
32. goloshchapov, D. L., Kashkarov, V. M., Rumyantseva, n. 
A., Seredin, P. V., Lenshin, A. S., Agapov, B. L., Doma-
shevskaya, E. P., Synthesis of nanocrystalline hydroxyapa-
tite by precipitation using hen’s eggshell, Ceram. Inter. 39 
(2013) 4539.
doi: https://doi.org/10.1016/j.ceramint.2012.11.050
33. Mohd Pu’ad, n. A. S., Koshy, P., Abdullah, H. Z., Idris, M. 
I., Lee, T. C., Syntheses of hydroxyapatite from natural 
sources, Heliyon 5 (2019) e01588.
doi: https://doi.org/10.1016/j.heliyon.2019.e01588
34. Kumar, g. S., girija, E. K., Venkatesha, M., Karunakaran, 
g., Kolesnikov, E., Kuznetsov, D., One step method to syn-
thesize flower-like hydroxyapatite architecture using mus-
sel shell bio-waste as a calcium source, Ceram. Inter. 43 
(2017) 3457.
doi: https://doi.org/10.1016/j.ceramint.2016.11.163
35. Sathiskumar, S., Vanaraj, S., Sabarinathan, D., Bharath, S., 
Sivarasan, g., Arulmani, S., Preethi, K., Ponnusamy, V. K., 
Green synthesis of biocompatible nanostructured hydroxy-
apatite from Cirrhinus mrigala fish scale – A biowaste to 
biomaterial, Ceram. Inter. 45 (2019) 7804.
doi: https://doi.org/10.1016/j.ceramint.2019.01.086
36. gibson, I. R., Bonfield, W., Novel synthesis and characteri-
zation of an AB-type carbonate-substituted hydroxyapatite, 
J. Biomed. Mater. Res. 59 (2002) 697.
doi: https://doi.org/10.1002/jbm.10044
37. Lafon, J. P., Champion, E., Bernache-Assollant, D., Pro-
cessing of AB-type carbonated hydroxyapatite 
Ca10−x(PO4)6−x(CO3)x(OH)2−x−2y(CO3)y ceramics with con-
trolled composition, J. Eur. Ceram. Soc. 28 (2008) 139.
doi: https://doi.org/10.1016/j.jeurceramsoc.2007.06.009
38. Birchall, J. D., Thomas, n. L., On the architecture and 
function of cuttlefish bone, J. Mater. Sci. 18 (1983) 2081.
doi: https://doi.org/10.1007/BF00555001
39. Hewitt, R. A., Analysis of aragonite from the cuttlefish bone 
of Sephia officinalis L., Mar. Geol. 18 (1975) M1.
doi: https://doi.org/10.1016/0025-3227(75)90033-X
40. Landi, E., Logroscino, g., Proietti, L., Tampieri, A., Sandri, 
M., Sprio, S., Biomimetic Mg-substituted hydroxyapatite: 
From synthesis to in vivo behaviour, J. Mater. Sci. Mater. 
Med. 19 (2008) 239.
doi: https://doi.org/10.1007/s10856-006-0032-y
41. Sabet, A. S., Jabbari, A. H., Sedighi, M., Microstructural 
properties and mechanical behavior of magnesium/ 
hydroxyapatite biocomposite under static and high cycle 
fatigue loading, J. Compos. Mater. 0 (2017) 1.
doi: https://doi.org/10.1177/0021998317731822
42. Zhang, X., Chen, Y., Han, J., Mo, J., Dong, P., Zhuo, Y., 
Feng, Y., Biocompatible silk fibroin/carboxymethyl chi-
tosan/strontium substituted hydroxyapatite/cellulose nano-
crystal composite scaffolds for bone tissue engineering, Int. 
J. Biol. Macromol. 136 (2019) 1247.
doi: https://doi.org/10.1016/j.ijbiomac.2019.06.172
43. Boanini, E., gazzano, M., Bigi, A., Ionic substitutions in 
calcium phosphates synthesized at low temperature, Acta 
Biomater. 6 (2010) 1882.
doi: https://doi.org/10.1016/j.actbio.2009.12.041
44. Chen, Y. H., Tai, H. Y., Fu, E., Don, T. M., Guided bone 
regeneration activity of different calcium phosphate/chi-
tosan hybrid membranes, Int. J. Biol. Macromol. 126 
(2019) 159.
doi: https://doi.org/10.1016/j.ijbiomac.2018.12.199
45. Dorozhkin, S. V., Amorphous calcium (ortho)phosphates, 
Acta Biomater. 6 (2010) 4457.
doi: https://doi.org/10.1016/j.actbio.2010.06.031
46. Rogina, A., Antunović, M., Milovac, D., Biomimetic design 
of bone substitutes based on cuttlefish bone-derived 
hydroxyapatite and biodegradable polymers, J. Biomed. 
Mater. Res. B Appl. Biomater. 107 (2019) 197.
doi: https://doi.org/10.1002/jbm.b.34111
47. Liao, C. J., Lin, F. H., Chen, K. S., Sun, J. S., Thermal 
decomposition and reconstruction of hydroxyapatite in air 
atmosphere, Biomed. Sci. Instrum. 35 (1999) 99.
doi: https://doi.org/10.1016/s0142-9612(99)00076-9
48. Stipniece, L., Salma-Ancane, K., Borodajenko, M., 
Sokolova, M., Jakovlevs, D., Berzina-Cimdina, L., Charac-
terization of Mg-substituted hydroxyapatite synthesized by 
wet chemical method, Ceram. Int. 40 (2014) 3261.
doi: https://doi.org/10.1016/j.ceramint.2013.09.110
49. Chocholata, P., Kulda, V., Babuska, V., Fabrication of scaf-
folds for bone-tissue regeneration, Materials 12 (2019) 568.
doi: https://doi.org/10.3390/ma12040568
A. Ressler et al., From Bio-waste to Bone Substitute…, Chem. Biochem. Eng. Q., 34 (2) 59–71 (2020) 71
50. Pawlak, A., Mucha, M., Thermogravimetric and FTIR stud-
ies of chitosan blends, Thermochim. Acta 396 (2003) 153.
doi: https://doi.org/10.1016/S0040-6031(02)00523-3
51. Kim, B. S., Kang, H. J., Yang, S. S., Lee, J., Comparison of 
in vitro and in vivo bioactivity: Cuttlefish-bone-derived 
hydroxyapatite and synthetic hydroxyapatite granules as a 
bone graft substitute, Biomed. Mater. 9 (2014) 025004.
doi: https://doi.org/10.1088/1748-6041/9/2/025004
52. Braux, J., Velard, F., guillaume, C., Bouthors, S., Jallot, E., 
nedelec, J. M., Laurent- Maquin, D., Laquerrière, P., A 
new insight into the dissociating effect of strontium on 
bone resorption and formation, Acta Biomater. 7 (2011) 
2593.
doi: https://doi.org/10.1016/j.actbio.2011.02.013
53. neves, n., Linhares, D., Costa, g., Ribeiro, C. C., Barbosa, 
M. A., In vivo and clinical application of strontium-en-
riched biomaterials for bone regeneration: A systematic 
review, Bone Joint. Res. 6 (2017) 366.
doi: https://doi.org/10.1302/2046-3758.66.BJR-2016-0311.R1
